Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERACYTE, INC. Director's Dealing 2019

Dec 9, 2019

31551_dirs_2019-12-09_e948ec2b-7511-45c9-942e-afe458c63ab2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2019-12-05

Reporting Person: Kennedy Keith (COO / CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-05 Common Stock M 11942 $7.47 Acquired 121645 Direct
2019-12-05 Common Stock M 7358 $5.98 Acquired 129003 Direct
2019-12-05 Common Stock S 19300 $30.0036 Disposed 109703 Direct
2019-12-06 Common Stock M 13851 $7.47 Acquired 123554 Direct
2019-12-06 Common Stock S 13851 $30.0445 Disposed 109703 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-05 Stock Option (right to buy) $7.47 M 11942 Disposed 2026-12-05 Common Stock (11942.0) Direct
2019-12-05 Stock Option (right to buy) $5.98 M 7358 Disposed 2028-03-01 Common Stock (7358.0) Direct
2019-12-06 Stock Option (right to buy) $7.47 S 13851 Disposed 2026-12-05 Common Stock (13851.0) Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.

F2: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F3: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.50. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F4: Beginning on December 6, 2017, 1/36 of the of shares vest each month for the following 36 months.

F5: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.